Composition
| Ingredient |
Amount |
Unit |
| Each ml of NEOZAND® contains : |
|
|
| neomycin sulfate |
200 |
mg |
Mechanism of action
Neomycin is an aminoglycoside antibiotic. Following entry into the bacterial cell, it specifically binds to the 30S ribosomal subunit. Binding of neomycin interferes with formation of the translation initiation complex and causes misreading of mRNA, resulting in the synthesis of abnormal and nonfunctional proteins. This disruption of translation ultimately results in the bactericidal activity of neomycin. Uptake of neomycin into bacterial cells is an energy- and oxygen-dependent process; therefore, its activity is mainly directed against susceptible aerobic bacteria.
Following oral administration, neomycin is absorbed from the gastrointestinal tract only to a very limited extent, with most of the drug remaining within the gastrointestinal tract and being excreted unchanged in the feces. Consequently, orally administered neomycin acts predominantly within the gastrointestinal tract and may be used for the treatment of enteric infections caused by susceptible bacteria, particularly certain Gram-negative bacteria.
Target species
Broilers, Turkeys, Calves, Lambs, and Kids
Indications
NEOZAND® is indicated for the treatment of bacterial infections susceptible to neomycin, including bacterial enteritis caused by Escherichia coli; and secondary bacterial infections associated with blue comb disease in turkeys.
Packaging
1 L polyethylene bottles
Storage Conditions
Store below 25°C, protected from direct light, in the original packaging. After opening, keep the container cap tightly closed. Protect from freezing.